DexCom Total Long Term Liabilities 2010-2024 | DXCM

DexCom total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • DexCom total long term liabilities for the quarter ending September 30, 2024 were $2.640B, a 0.35% decline year-over-year.
  • DexCom total long term liabilities for 2023 were $2.64B, a 85.83% increase from 2022.
  • DexCom total long term liabilities for 2022 were $1.421B, a 34.55% decline from 2021.
  • DexCom total long term liabilities for 2021 were $2.17B, a 17.33% increase from 2020.
DexCom Annual Total Long Term Liabilities
(Millions of US $)
2023 $2,640
2022 $1,421
2021 $2,170
2020 $1,850
2019 $1,152
2018 $1,030
2017 $346
2016 $17
2015 $4
2014 $4
2013 $6
2012 $10
2011 $1
2010 $1
2009 $47
DexCom Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $2,640
2024-06-30 $2,643
2024-03-31 $2,641
2023-12-31 $2,640
2023-09-30 $2,650
2023-06-30 $2,651
2023-03-31 $1,418
2022-12-31 $1,421
2022-09-30 $2,174
2022-06-30 $2,155
2022-03-31 $2,156
2021-12-31 $2,170
2021-09-30 $1,905
2021-06-30 $1,906
2021-03-31 $1,883
2020-12-31 $1,850
2020-09-30 $1,828
2020-06-30 $1,768
2020-03-31 $1,171
2019-12-31 $1,152
2019-09-30 $1,099
2019-06-30 $1,089
2019-03-31 $1,070
2018-12-31 $1,030
2018-09-30 $358
2018-06-30 $355
2018-03-31 $350
2017-12-31 $346
2017-09-30 $341
2017-06-30 $337
2017-03-31 $18
2016-12-31 $17
2016-09-30 $14
2016-06-30 $13
2016-03-31 $4
2015-12-31 $4
2015-09-30 $5
2015-06-30 $4
2015-03-31 $4
2014-12-31 $4
2014-09-30 $4
2014-06-30 $5
2014-03-31 $5
2013-12-31 $6
2013-09-30 $8
2013-06-30 $9
2013-03-31 $9
2012-12-31 $10
2012-09-30 $2
2012-06-30 $2
2012-03-31 $2
2011-12-31 $1
2011-09-30 $1
2011-06-30 $1
2011-03-31 $2
2010-12-31 $1
2010-09-30 $2
2010-06-30 $4
2010-03-31 $6
2009-12-31 $47
2009-09-30 $46
2009-06-30 $47
2009-03-31 $48
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $29.615B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.634B 24.11
Intuitive Surgical (ISRG) United States $186.606B 97.56
Edwards Lifesciences (EW) United States $43.604B 27.69
Alcon (ALC) Switzerland $41.521B 27.78
IQVIA Holdings (IQV) United States $34.761B 19.15
IDEXX Laboratories (IDXX) United States $33.493B 39.44
Waters (WAT) United States $21.413B 31.66
STERIS (STE) Ireland $20.170B 23.22
SONOVA HOLDING (SONVY) Switzerland $19.359B 0.00
Hologic (HOLX) United States $16.058B 17.34
Fresenius Medical Care AG KGaA (FMS) Germany $13.192B 13.54
Sysmex ADR (SSMXY) Japan $11.726B 36.77
Globus Medical (GMED) United States $11.158B 28.25
Penumbra (PEN) United States $9.346B 91.55
Masimo (MASI) United States $9.102B 44.04
Teleflex (TFX) United States $8.118B 12.95
Glaukos (GKOS) United States $7.925B 0.00
Integer Holdings (ITGR) United States $4.457B 25.26
PROCEPT BioRobotics (PRCT) United States $4.215B 0.00
Inari Medical (NARI) United States $3.185B 0.00
Veracyte (VCYT) United States $3.028B 90.86
Nihon Kohden (NHNKY) Japan $2.590B 19.67
LivaNova (LIVN) United Kingdom $2.579B 14.89
Tandem Diabetes Care (TNDM) United States $2.185B 0.00
Elekta AB (EKTAY) Sweden $2.096B 18.84
TransMedics (TMDX) United States $2.031B 64.39
Integra LifeSciences Holdings (IART) United States $1.675B 8.75
RxSight (RXST) United States $1.539B 0.00
Alphatec Holdings (ATEC) United States $1.255B 0.00
Artivion (AORT) United States $1.173B 77.69
Pulse Biosciences (PLSE) United States $1.094B 0.00
OPKO Health (OPK) United States $1.072B 0.00
Paragon 28 (FNA) United States $0.820B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.760B 12.92
Mesa Laboratories (MLAB) United States $0.714B 16.83
IRadimed (IRMD) United States $0.676B 36.54
ORTHOFIX MEDICAL INC (OFIX) United States $0.657B 0.00
AxoGen (AXGN) United States $0.654B 0.00
Semler Scientific (SMLR) United States $0.568B 29.92
SiBone (SIBN) United States $0.547B 0.00
OrthoPediatrics (KIDS) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Treace Medical Concepts (TMCI) United States $0.430B 0.00
Tactile Systems Technology (TCMD) United States $0.407B 22.01
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.357B 0.00
AngioDynamics (ANGO) United States $0.349B 0.00
NeuroPace (NPCE) United States $0.333B 0.00
CVRx (CVRX) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.219B 0.00
Inogen (INGN) United States $0.198B 0.00
Accuray (ARAY) United States $0.180B 0.00
Sight Sciences (SGHT) United States $0.171B 0.00
KORU Medical Systems (KRMD) United States $0.170B 0.00
Nevro (NVRO) United States $0.135B 0.00
Atossa Genetics (ATOS) United States $0.123B 0.00
Sensus Healthcare (SRTS) United States $0.118B 12.65
Spectral Diagnostics (EDTXF) Canada $0.094B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Vicarious Surgical (RBOT) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
908 Devices (MASS) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.058B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.044B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Envoy Medical (COCH) United States $0.037B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.008B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Check-Cap (CHEK) Israel $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00